Capricor Therapeutics, Inc. (CAPR) Revenue Growth
Capricor Therapeutics, Inc. (CAPR) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | -33.32% |
| 2018-12-31 | -37.32% |
| 2019-12-31 | N/A |
| 2020-12-31 | N/A |
| 2021-12-31 | -21.06% |
| 2022-12-31 | 941.85% |
| 2023-12-31 | 886.81% |
| 2024-12-31 | -11.43% |
| 2025-12-31 | N/A |
How CAPR compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| VERU | Veru Inc. | 3.62% |
| BNTC | Benitec Biopharma Inc. | 2.74% |
| ARVN | Arvinas Inc. | -0.30% |
| EYPT | EyePoint Pharmaceuticals Inc. | -27.50% |
| PLSE | Pulse Biosciences Inc | -50.63% |
These are five companies in the same sector as CAPR with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Capricor Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("CAPR", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CAPR | $9.59 | -4.67% | 5.19M |
| 3 | ||||
| 4 | ||||
| 5 |